MediPharm Labs Corp (MEDIF)
0.0540
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
MediPharm Labs Shareholders Equity (Quarterly): 36.90M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 36.90M |
| December 31, 2023 | 39.96M |
| September 30, 2023 | 40.61M |
| June 30, 2023 | 44.53M |
| March 31, 2023 | 39.67M |
| December 31, 2022 | 41.27M |
| September 30, 2022 | 44.22M |
| June 30, 2022 | 53.21M |
| March 31, 2022 | 61.00M |
| December 31, 2021 | 65.21M |
| September 30, 2021 | 80.45M |
| June 30, 2021 | 88.33M |
| March 31, 2021 | 94.08M |
| Date | Value |
|---|---|
| December 31, 2020 | 61.49M |
| September 30, 2020 | 78.73M |
| June 30, 2020 | 86.38M |
| March 31, 2020 | 83.67M |
| December 31, 2019 | 100.70M |
| September 30, 2019 | 97.43M |
| June 30, 2019 | 92.18M |
| March 31, 2019 | 25.66M |
| September 30, 2018 | 0.3306M |
| June 30, 2018 | 0.3745M |
| March 31, 2018 | 0.3968M |
| December 31, 2017 | 0.3006M |
| September 30, 2017 | 0.3216M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
36.90M
Minimum
Mar 2024
100.70M
Maximum
Dec 2019
66.50M
Average
63.35M
Median
Shareholders Equity (Quarterly) Benchmarks
| Venus Concept Inc | -22.49M |
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.33M |
| Total Liabilities (Quarterly) | 8.430M |
| Debt to Equity Ratio | 0.0397 |
| Current Ratio | 3.069 |
| Net Debt Paydown Yield | -0.84% |